An elective combined caesarean section and small bowel GIST resection during the third trimester of pregnancy: Report of a case  by Haloob, N. et al.
A
t
N
a
b
c
d
a
A
R
A
A
K
G
G
P
1
m
a
m
p
r
a
p
g
i
s
w
2
s
o
h
s
i
7
O
2
hCASE  REPORT  –  OPEN  ACCESS
International Journal of Surgery Case Reports 4 (2013) 121– 124
Contents lists available at SciVerse ScienceDirect
International  Journal  of  Surgery  Case  Reports
j ourna l ho me page: www.elsev ier .com/ locate / i j scr
n  elective  combined  caesarean  section  and  small  bowel  GIST  resection  during
he  third  trimester  of  pregnancy:  Report  of  a  case
.  Halooba,∗, A.A.P.  Slesserb, A.R.  Haloobc, F.  Khanc, G.  Bostanci c, A.  Abdullad
Lister Hospital, Corey Mill Lane, Stevenage, Hertfordshire SG1 4AB, United Kingdom
General Surgery, Chase Farm Hospital, The Ridgeway, Enﬁeld, Middlesex EN2 8JL, United Kingdom
Basildon and Thurrock University Hospital, Nethermayne, Essex SS16 5NL, United Kingdom
Pathology Department, Basildon and Thurrock University Hospital, Nethermayne, Essex SS16 5NL, United Kingdom
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 31 August 2012
ccepted  23 October 2012
vailable online 31 October 2012
eywords:
a  b  s  t  r  a  c  t
INTRODUCTION:  Gastro-Intestinal  Stromal  Tumours  (GISTs)  are  rare  with  an  estimated  incidence  of  only
11–15  per million.  In  pregnancy,  GISTs  are  an extremely  rare  occurrence  and  are  thus  complex  to  manage
from  an ethical,  surgical  and  oncological  perspective.
PRESENTATION OF  CASE:  We  present  the  ﬁrst  reported  case  in the  literature  of  a  successful  combined  lower
segment  caesarean  section  (LSCS)  and  a tumour  resection  in a 31-year-old  pregnant  patient  presentingIST
astro-Intestinal Stromal Tumour
regnancy
with  a small  bowel  GIST.
DISCUSSION: We  compare  and  contrast  our  case  with  other  reported  cases  of  GIST  resection  in  pregnancy
and  discuss  the  challenges  faced  by  both  patients  and  clinicians.
CONCLUSION: Our case demonstrates  that  a combined  LSCS  and  GIST  resection  is feasible.  In  addition,  our
case  highlights  the importance  of  both  the  multidisciplinary  setting  and the  consideration  of  patients’
ana
 Publiwishes  in  the  successful  m
Crown Copyright © 2012 
. Introduction
Gastro-Intestinal Stromal Tumours (GISTs) are the most com-
on mesenchymal tumours of the gastro-intestinal tract.1 They
re rare with an estimated annual incidence of only 11–15 per
illion.2,3 GISTs are found equally in both genders and commonly
resent in the ﬁfth to seventh decade.4,5 They thus present very
arely in pregnancy. The exact incidence in pregnancy is unknown
s there are few reported cases in the literature. The management of
regnant patients presenting with GISTs poses a challenge to both
eneral surgeons and obstetricians. We  present the ﬁrst case report
n the literature to describe a combined lower segment caesarean
ection and a tumour resection in a pregnant women presenting
ith a GIST.
.  Presentation of case
A 31-year-old woman of Chinese origin, gravida 2 para 0, pre-
ented at 18 weeks gestation to the antenatal clinic complaining
f lethargy, dizziness and shortness of breath on exertion. She
ad no signiﬁcant past medical history, normal antenatal con-
ultations to date, and was not on regular medications. Routine
CC BY-NC-ND license.nvestigations demonstrated a microcytic anaemia; haemoglobin
.8 g/dl, MCV  72.9 ﬂ, platelets 539, and serum ferritin of 13 g/l.
n examination, her uterus was consistent for the date of
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210-2612 Crown Copyright ©  2012 Published by Elsevier Ltd on behalf of Surgical Asso
ttp://dx.doi.org/10.1016/j.ijscr.2012.10.017gement  of  this  complex  group  of  patients.
shed by Elsevier Ltd on behalf of Surgical Associates Ltd. 
gestation. Per vaginal examination revealed a large palpable
mass in the right adnexa. A subsequent ultrasound demon-
strated an ‘irregular mass of mixed echogenicity measuring
106.4 mm ×68.7 mm ×109.5 mm’  suggestive of a ﬁbroid or an
ovarian pathology. A Magnetic Resonance Imaging (MRI) scan of
the abdomen and pelvis was  thus organised and demonstrated an
irregular 12 cm soft tissue mass in the right upper quadrant (Fig. 1).
The mass appeared to involve the transverse mesocolon as well as
part of the small bowel mesentery with associated extensive necro-
sis (Fig. 1). An ultrasound guided biopsy of the soft tissue mass was
organised at 30 weeks gestation, conﬁrming a GIST of uncertain
malignant potential (Fig. 2). It was  decided at a multidisciplinary
meeting to perform an elective combined caesarean section and
tumour resection.
At  36 weeks gestation, a healthy baby girl weighing 2.15 kg was
delivered by a lower segment caesarean section through a midline
laparotomy. The tumour was found to arise from the mid jejunum
and also involved the ascending colon. There was  no evidence of
intra abdominal metastasis. An extended right hemicolectomy and
segmental resection of the jejunum with an end-to-side ileocolic
and a jejunojejunal anastomoses were successfully performed. The
resected tumour weighed 2.5 kg (Fig. 3).
Histology conﬁrmed a GIST arising from the small bowel wall
with inﬁltration into the serosal aspect of colon but no muscular
invasion. All resection margins were clear. Immunohistochemistry
conﬁrmed strong positivity for CD117 (c-kit) and focal strong posi-
tivity of CD34 with a mitotic rate of >50/50 HPF (high power ﬁeld).
Open access under Subsequent gene mutation analysis demonstrated a large deletion
in exon 11 C-KIT gene.
ciates Ltd. Open access under CC BY-NC-ND license.
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Fig. 1. Coronal MRI  demonstrating intrauterine foetus (blue arrow) and intraab-
dominal  GIST (white arrow). (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of the article.)
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Fig. 2. CD-117-labelled immunohistochemistry of resected tumour, conﬁrming
IST  (200× magniﬁcation).The patient made an uneventful post-operative recovery and
as successfully discharged. She was commenced on a 2-year
ourse of adjuvant Imatinib. At a 2-year follow up, the patient
ig. 3. Macroscopic appearance of resected tumour and adherent large bowel.PEN  ACCESS
rgery Case Reports 4 (2013) 121– 124
was asymptomatic with no evidence of recurrence on computed
tomography (CT) imaging.
3.  Discussion
GISTs are known to arise from KIT positive Cajal cells, that are
spindle cells located close to the Auerbach plexus.6,7 C-KIT is a tyro-
sine kinase receptor for stem cell factor and it is the mutation of this
receptor that is thought to be crucial in the development of GISTs.6
Exon 11 deletions, as was encountered in our case, are the most
common form of KIT mutation found in small bowel GISTS.6
The ﬁnding of an intra-abdominal GIST in pregnancy is
extremely rare with only three other cases describing this ﬁnding
in the literature (Table 1).8–10 The most common sites of gastroin-
testinal tract GISTs are the stomach (60–75%) followed by the small
intestine (20–30%).11,12 Interestingly, perhaps due to the limited
number of studies, there was  no evident difference in incidence of
gastric and small intestine GISTs in the reported cases (Table 1).
The tumour size, upon presentation, can vary considerably ranging
from anywhere between 2 and 20 cm.5 This is consistent with the
reported cases of GISTs in pregnancy with the tumour sizes ranging
between 4 and 17 cm (Table 1). Metastatic spread is rare, usually
occurring by either trans-coelomic or haematogenous spread to
organs such as the liver, lung and bone.4,5
In our case and those previously reported, the presentation and
symptoms of GISTs in pregnancy have been non-speciﬁc (Table 1).
In general, small asymptomatic GISTs are usually diagnosed inci-
dentally during endoscopy or surgery for other indications.11
Symptoms usually occur as a result of the ‘mass effect’ of the tumour
but can occasionally present with microcytic anaemia or haema-
tochesia as a result of gastrointestinal bleeding.11,13 Rarely, patients
may present acutely due to either an obstruction or a perforation
of a viscus.14 Constitutional symptoms are not uncommon in preg-
nancy and thus the presentation of GISTs in pregnancy can pose a
diagnostic challenge.8
Attaining a diagnosis in pregnancy is difﬁcult, as it
is normally recommended that computed tomography is
undertaken to accurately stage the tumour.11,15 Ultra-
sound is safe in pregnancy and was used in all the
reported cases to initially assess the tumour (Table 1).
However, ultrasound imaging is non-speciﬁc. MRI  scanning is
recognised as a helpful imaging modality in the diagnosis of GISTs
and in pregnancy this is the imaging of choice.11 A tissue biopsy
will stain positive on immunohistochemistry for CD117 and CD34
in 90% and 70% of GISTs respectively.12 However, care must be
taken as there is a theoretical risk of tumour cell seeding and
it should only really be undertaken if there is a clear diagnostic
uncertainty.11 Once the diagnosis of a GIST has been conﬁrmed in
the absence of metastatic disease, a surgical resection remains the
only curative option.1,11 There remains some controversy about
GISTs smaller than two cm with current European guidelines
recommending close follow up for gastric or duodenal lesions less
than two  centimetres and resecting only if there is an increase in
size.15
Surgical management of small bowel GISTS, as was found in
our case, should include an exploratory laparotomy at the time of
surgery to exclude metastases.11 Small bowel GISTs can be safely
excised using a segmental resection due to the fact that GISTs rarely
metastasise lymphatically.11 During tumour resection, care should
be taken to ensure that the pseudo-capsule remains intact to pre-
vent the spread of tumour cells.11 The difﬁculty in the surgical
management of pregnant patients presenting with GISTs is deciding
the optimal timing of the surgery; the balance of good oncological
repsonse and minimising injury to the foetus. Unfortunately, due
to the rarity of the condition there are no current guidelines for the
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management of GISTs in pregnancy. In the other reported cases,
the tumour resection was performed antenatally (Table 1). How-
ever, one of the antenatal resections resulted in an emergency LSCS
1 h post operatively due to foetal distress (Table 1). The timing of
surgery in our case was largely dictated by the patient’s wishes,
as she did not want to have an antenatal resection, and thus it
was decided in a multi-disciplinary setting, to perform a LSCS fol-
lowed by a resection of the tumour in one sitting. It is clear that
there is no deﬁnitive answer to the question of what constitutes the
optimal timing of surgery in these patients and thus any key man-
agement decisions should be made in a multidisciplinary (MDT)
setting involving oncologists, general surgeons and obstetricians
whilst also taking into account the patients’ wishes.
The use of Imatinib in a neo-adjuvant and adjuvant setting for
GISTs remains controversial with limited survival data available
from current trials.1 Neo-adjuvant Imatinib is currently recom-
mended if a RO resection cannot be attained or where reduction of
the tumour size will reduce the risk of mutilating surgery.1 How-
ever as little is known on the teratogenic effects of Imatinib, its use
during gestation should only be used on a case to case basis.16 Adju-
vant Imatinib is recommended for localised GISTs where there is a
high risk of recurrence.1 The risk of recurrence is stratiﬁed accord-
ing to the size and mitotic count of the tumour.1 Furthermore, the
site of the GIST is also a contributing factor in determining the risk of
recurrence with small bowel GISTs having a higher risk than gastric
GISTs.1,11 A size greater than ﬁve cm with a mitotic count greater
than 5/50, as was found in our case, stratiﬁes a GIST as ‘high’ risk
and therefore adjuvant Imatinib therapy was  commenced.
There are no clear international or national guidelines on the
optimal follow up for patients with GISTs.1,15,17 Most recurrences
occur in the liver or the peritoneum and will thus be best detected
with CT scanning at appropriate interval follow up.15
4. Conclusion
This is the ﬁrst reported case of a combined successful delivery
and GIST resection in a pregnant patient. Our case demonstrates the
complexity of managing pregnant patients presenting with GISTs
from an ethical, surgical and oncological perspective. There are no
guidelines on the optimal timing of the tumour resection in preg-
nancy and thus key management decisions should be taken in a
MDT  setting whilst taking into account the patient’s wishes.
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